People: Anthera Pharmaceuticals Inc (ANTH.O)
17 Dec 2013
Dr. Debra Odink, Ph.D., serves as Senior Vice President, Chief Technology Officer of Anthera Pharmaceuticals Inc., since December 2011. Prior to that, she served as Senior Vice President of Pharmaceutical Research and Development since June 2010, and as Vice President of Pharmaceutical Research and Development since December 2005. From September 2002 until July 2005, Dr. Odink served as Vice President of Pharmaceutical Chemistry and Product Development at Peninsula Pharmaceuticals, Inc., a biopharmaceutical company, where she was responsible for manufacturing and product development strategies for assets licensed to Peninsula. Dr. Odink holds a B.S. in chemistry from California State University, Stanislaus and a Ph.D. in inorganic chemistry from the University of California at Davis.
|Total Annual Compensation, USD||Long-Term Incentive Plans, USD||All Other, USD||Fiscal Year Total, USD|